Singh Sheela P, Yang Dan, Ravoori Murali, Han Lin, Kundra Vikas
Department of Experimental Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 368, Houston, TX 77030, USA.
Radiology. 2009 Sep;252(3):763-71. doi: 10.1148/radiol.2531081825. Epub 2009 Jul 8.
To assess whether a combination of in vivo anatomic and functional imaging can help quantify expression of somatostatin receptor type 2 (SSTR2)-based reporters after in vivo gene transfer.
All animal experiments were approved by an institutional animal care and use committee. Six nude mice bearing two subcutaneous L3.6pl (human pancreatic cancer) tumors were injected intratumorally with an adenovirus containing a human somatostatin receptor type 2 gene chimera (Ad-HA-SSTR2) or a control adenovirus containing green fluorescent protein (Ad-GFP). Two days later, magnetic resonance (MR) imaging was performed to derive tumor weight and analyze morphology. Intravenous injection of Food and Drug Administration-approved indium 111 octreotide was followed by gamma camera imaging (planar imaging and single photon emission computed tomography [SPECT]) the next day. Region-of-interest analysis followed. The procedure was also performed in six nude mice with slow-growing MDA-MB-435 (human breast carcinoma) tumors, which allowed serial imaging 3 days and 2 weeks after adenovirus injection. After imaging, excised tumor weight and biodistribution were assessed. Statistical analyses included a Student t test and linear regression.
With both tumor types, ex vivo and image-based in vivo biodistribution demonstrated greater uptake (percentage of injected dose per gram) in tumors infected with Ad-HA-SSTR2 than in those infected with Ad-GFP (P < .05). Furthermore, in vivo and ex vivo biodistribution analysis correlated (ex vivo vs planar and MR imaging: r = 0.87, P < .05, n = 24; ex vivo vs SPECT and MR imaging: r = 0.84, P < .05, n = 24). Moreover, in vivo biodistribution distinguished greater expression at the earlier time point in MDA-MB-435 tumors infected with Ad-HA-SSTR2 from waning expression at the later time point (P < .05).
A combination of in vivo functional and anatomic imaging methods can help quantify gene expression after in vivo gene transfer.
评估体内解剖成像与功能成像相结合是否有助于在体内基因转移后对基于生长抑素受体2(SSTR2)的报告基因的表达进行定量分析。
所有动物实验均经机构动物护理和使用委员会批准。对6只携带两个皮下L3.6pl(人胰腺癌)肿瘤的裸鼠进行瘤内注射含有人生长抑素受体2基因嵌合体的腺病毒(Ad-HA-SSTR2)或含有绿色荧光蛋白的对照腺病毒(Ad-GFP)。两天后,进行磁共振(MR)成像以得出肿瘤重量并分析形态。静脉注射经美国食品药品监督管理局批准的铟111奥曲肽,次日进行γ相机成像(平面成像和单光子发射计算机断层扫描[SPECT])。随后进行感兴趣区域分析。该程序也在6只患有生长缓慢的MDA-MB-435(人乳腺癌)肿瘤的裸鼠中进行,这使得在腺病毒注射后3天和2周进行连续成像成为可能。成像后,评估切除肿瘤的重量和生物分布。统计分析包括学生t检验和线性回归。
对于两种肿瘤类型,体外和基于图像的体内生物分布均显示,感染Ad-HA-SSTR2的肿瘤比感染Ad-GFP的肿瘤摄取量更高(每克注射剂量的百分比)(P <.05)。此外,体内和体外生物分布分析具有相关性(体外与平面成像和MR成像:r = 0.87,P <.05,n = 24;体外与SPECT和MR成像:r = 0.84,P <.05,n = 24)。此外,体内生物分布区分出感染Ad-HA-SSTR2的MDA-MB-435肿瘤在较早时间点有更高的表达,而在较晚时间点表达逐渐减弱(P <.05)。
体内功能成像与解剖成像方法相结合有助于在体内基因转移后对基因表达进行定量分析。